Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6751
Rank
S$0.82 B
Marketcap
S$41.38
Share price
-0.08%
Change (1 day)
-3.58%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$60.93 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are S$60.93 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$57.44 M11.33%
2023-12-31S$51.6 M